Skip to Content

Pan Tumor Study – Effectively Treatment for HER2-Expressing Cancers Regardless of Tumor Location

Trastuzumab deruxtecan (Enhertu®) is an effective treatment option for patients with difficult-to-treat HER2-expressing solid tumors, according to these findings from an international study uncovering effectiveness across tumor locations.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top